The Cancer Dependency Map: Revealing cancers' genetic and drug vulnerabilities at scale

Ideally doctors could look at the molecular profile of any patient's cancer and immediately say which treatments will most likely benefit that person. In this short video, Broad Cancer Program director and chief scientific officer Todd Golub explains how the Cancer Dependency Map is helping make that vision a reality: By systematically probing all of the drug sensitivities and genetic vulnerabilities of hundreds of cancer cell lines.